Carillion
OTCMKTS:CIOIFCarillion plc operates as an integrated support services company in the United Kingdom, the Middle East and North Africa, Canada, and the rest of the world. The company operates through four segments: Support Services, Public Private Partnership (PPP) Projects, Middle East Construction Services, and Construction Services (Excluding the Middle East). It provides maintenance, facilities management, and energy services to buildings and large property estates, and public and private sectors; infrastructure services for roads, railways, and utility networks, primarily telecommunications and power transmission and distribution sectors; and remote site accommodation and consultancy services. The company also offers project finance, support, and construction services for public private partnership projects to deliver public sector buildings and infrastructure; and construction, civil engineering and development, and consultancy services to a range of buildings and infrastructure focusing on contracts for long-term public and private sector customers. It serves aviation, corporate, financial services, oil and gas, central and local government, defense, healthcare, transport, education, commercial and retail, and residential and leisure sectors. Carillion plc was incorporated in 1999 and is headquartered in Wolverhampton, the United Kingdom.
Nextech3D.AI
OTCMKTS:NEXCFNextech3D.AI Corporation provides augmented reality technologies, wayfinding technologies, and 3D model services. It focuses on creating 3D WebAR photorealistic models for the prime ecommerce marketplace, as well as other online retailers. The company was formerly known as NexTech AR Solutions Corp. and changed its name to Nextech3D.AI Corporation in September 2023. Nextech3D.AI Corporation was incorporated in 2018 and is headquartered in Toronto, Canada.
Nicox
OTCMKTS:NICXFNicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial. The company is also developing NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals that is in Phase 2b clinical trial for the treatment of dry eye disease; and NCX 1728, an NO-donating Phosphodiesterase-5 inhibitor, which is in preclinical evaluation. It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was incorporated in 1996 and is headquartered in Valbonne, France.
Noble Group
OTCMKTS:NOBGYNoble Group Limited is in the process of liquidation. Previously, the company was operated as an independent energy products and industrial raw materials supply chain manager. Its Energy segment was engaged in trading energy coal and the provision of supply chain and risk management services in bituminous and sub-bituminous energy coal, as well as in seaborne LNG. The company's Metals, Minerals and Ores segment was involved in trading and providing supply chain management services in copper, zinc, lead, nickel, and other raw materials, as well as aluminum, alumina, and bauxite. The company was also engaged in trading and providing risk management and logistics services for the steel complex in iron ore, metallurgical coal, metallurgical coke, specialty ores and alloys, and industrial metals and minerals, as well as offered ocean transport in the dry bulk segment, long term freight solutions, and freight market guidance. The company was founded in 1987 and is headquartered in London, the United Kingdom.